loadpatents
Patent applications and USPTO patent grants for Srifa; Waracharee.The latest application filed is for "pharmaceutical compositions comprising gene-corrected primary cells".
Patent | Date |
---|---|
Pharmaceutical Compositions Comprising Gene-corrected Primary Cells App 20220064676 - Dever; Daniel P. ;   et al. | 2022-03-03 |
Nuclease-mediated Genome Editing Of Primary Cells And Related Methods Of Treatment App 20220025408 - DEVER; DANIEL P. ;   et al. | 2022-01-27 |
Nuclease-mediated Genome Editing Of Primary Cells App 20220025409 - Dever; Daniel P. ;   et al. | 2022-01-27 |
Nuclease-mediated genome editing of primary cells and enrichment thereof Grant 11,193,141 - Dever , et al. December 7, 2 | 2021-12-07 |
Nuclease-Mediated Genome Editing of Primary Cells and Enrichment Thereof App 20190032091 - Dever; Daniel P. ;   et al. | 2019-01-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.